Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stephanie Beate Geisler"'
Autor:
Xavier Tekpli, Shom Goel, Barbro Holm, Lars-Egil Fallang, Laurens Cornelus Reitsma, Stephanie Beate Geisler, Hilde Presterud Ødegård, Cathrine Bergquist Fosskaug, Ida Caroline Lindem, Manouchehr Seyedzadeh, Jonn Terje Geitung, Joana Reis, Kjell Inge Gjesdal, Unn-Cathrin Buvarp, Marie Loeng, Kristine Kleivi Sahlberg, Alina Carmen Porojnicu, Helle Kristine Skjerven, Andliena Tahiri, Shakila Jabeen, Torben Lüders, Vahid Bemanian, Jørgen Jahnsen, Marianne Lyngra, Antoni Hurtado, Jason Carroll, Shiuan Chen, Vessela Kristensen, Jürgen Geisler
Publikováno v:
Cancer Research. 82:OT2-19
Background: The introduction of CDK4/6 inhibitors has been one of the most pivotal breakthroughs in breast cancer therapy in recent decades. A growing body of evidence now suggests that novel targeting inhibitors of CDK4/6, as well as MAPK and PI3K i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad78f2439a46e3b70096558da9c18d6f
https://doi.org/10.1158/1538-7445.sabcs21-ot2-19-01
https://doi.org/10.1158/1538-7445.sabcs21-ot2-19-01
Autor:
Nazli Bahrami, Shakila Jabeen, Torill Sauer, Hilde Presterud Ødegård, Stephanie Beate Geisler, Berit Gravdehaug, Laurens Cornelus Reitsma, Knut Selsås, Vessela Kristensen, Jürgen Geisler
Background: The aromatase inactivator exemestane may cause clinical disease stabilization following progression on non-steroidal aromatase inhibitors like letrozole in patients with metastatic breast cancer, indicating that additional therapeutic eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c18db6e02f7bce3cf37cfd2f780a7dda
https://doi.org/10.21203/rs.3.rs-62421/v1
https://doi.org/10.21203/rs.3.rs-62421/v1
